USE OF POLYMER D-LACTIC ACID (PDLA) OR EQUIVALENTS THEREOF TO INHIBIT GROWTH OF CANCER CELLS AND DIAGNOSE CANCER
Digital publications
- Digital Edition
Goldberg, JS; Weinberg, JB
December 30, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Publication Date
December 30, 2019
Publisher
USPTO
Citation
APA
Chicago
ICMJE
MLA
NLM
Goldberg, J. S., & Weinberg, J. B. (2019). USE OF POLYMER D-LACTIC ACID (PDLA) OR EQUIVALENTS THEREOF TO INHIBIT GROWTH OF CANCER CELLS AND DIAGNOSE CANCER. USPTO.
Goldberg, J. S., and J. B. Weinberg. “USE OF POLYMER D-LACTIC ACID (PDLA) OR EQUIVALENTS THEREOF TO INHIBIT GROWTH OF CANCER CELLS AND DIAGNOSE CANCER.” USPTO, December 30, 2019.
Goldberg JS, Weinberg JB. USE OF POLYMER D-LACTIC ACID (PDLA) OR EQUIVALENTS THEREOF TO INHIBIT GROWTH OF CANCER CELLS AND DIAGNOSE CANCER. USPTO; 2019.
Goldberg, J. S., and J. B. Weinberg. USE OF POLYMER D-LACTIC ACID (PDLA) OR EQUIVALENTS THEREOF TO INHIBIT GROWTH OF CANCER CELLS AND DIAGNOSE CANCER. USPTO, 30 Dec. 2019.
Goldberg JS, Weinberg JB. USE OF POLYMER D-LACTIC ACID (PDLA) OR EQUIVALENTS THEREOF TO INHIBIT GROWTH OF CANCER CELLS AND DIAGNOSE CANCER. USPTO; 2019.
Publication Date
December 30, 2019
Publisher
USPTO